A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

December 19, 2023

Primary Completion Date

November 2, 2035

Study Completion Date

November 2, 2035

Conditions
Multiple Myeloma
Interventions
DRUG

Linvoseltamab

Linvoseltamab will be administered by intravenous (IV) infusion

Trial Locations (30)

10016

RECRUITING

Perlmutter Cancer Center, New York

10032

RECRUITING

Columbia University _ New York Presbyterian, New York

11501

RECRUITING

Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola

11794

RECRUITING

Stony Brook University Hospital, Stony Brook

28006

RECRUITING

Universitary Hospital La Princesa, Madrid

28027

RECRUITING

Clinica Universidad de Navarra - Madrid, Madrid

28204

RECRUITING

Levine Cancer Institute, Charlotte

28223

RECRUITING

Hospital Universitario Quiron Salud Madrid, Pozuelo de Alarcón

31008

RECRUITING

Clinica Universidad de Navarra, Pamplona

33011

RECRUITING

Hospital Universitario Central De Asturias, Oviedo

37007

RECRUITING

Hospital Universitario de Salamanca, Salamanca

40207

RECRUITING

Norton Cancer Institute, Louisville

46026

RECRUITING

La Fe University Hospital, Valencia

48201

RECRUITING

Karmanos Cancer Institute, Detroit

59000

NOT_YET_RECRUITING

CHU De Lille, Lille

75010

RECRUITING

Hopital Saint Louis, Paris

75013

RECRUITING

Hopital Pitié Salpetriere APHP, Paris

75015

RECRUITING

Hopital Necker, Paris

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

80218

RECRUITING

Colorado Blood Cancer Institute/SCRI, Denver

86021

RECRUITING

Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers

90095

RECRUITING

University of California Los Angeles (UCLA), Los Angeles

92868

RECRUITING

UC Irvine Health, Orange

94800

RECRUITING

Gustave Roussy, Villejuif

342950

RECRUITING

Centre Hospitalier Universitaire (CHU) Montpellier, Montpellier

08901

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

08916

RECRUITING

Hospital Germans Trias i Pujol, Badalona

03010

RECRUITING

Hospital General Universitario Doctor Balmis Alicante, Alicante

08036

RECRUITING

Hospital Clinic de Barcelona, Barcelona

08908

RECRUITING

Institut Catala dOncologia (ICO Hospitalet), Barcelona

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY